BackNovavax Overview

Novavax Current Cash

Track Novavax's current cash ($230M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$228.36M
↓ 13.28% YoYΔ $-34.98M vs prior year quarter

Peer average

Loading

Novavax Current Cash History

Loading

Novavax vs. peers: Current Cash Comparison

Loading

Novavax Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Novavax (NVAX) FAQ

The latest current cash for NVAX is $230M as of March 2026. That compares with $260M in the prior-year period — down 13.3% year over year. Investors often review this figure alongside Novavax's historical trend and sector peers before judging valuation or financial health.

Over the past year, NVAX's current cash moved from $260M to $230M — a 13.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Novavax's operating scale or balance-sheet position.

A current cash figure of $230M for NVAX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NVAX's current cash ($230M), review year-over-year change from $260M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Novavax's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.